Global Kinetics
Thomas Ulmer is an experienced professional who has held various leadership positions in the finance and biotechnology industries. Currently serving as the Chief Operating and Financial Officer at PKG Health, Thomas has also been involved in companies such as Global Kinetics Pty Ltd, Aravax, Immatics Biotechnologies, Allergopharma GmbH & Co. KG, EggShell GmbH, Merck Group, Merck Pty Ltd, Alphapharm, and Merck Generics Holding GmbH. With a strong educational background, including a Master's degree in Finance & Banking, Thomas has proven expertise in finance, accounting, business planning, and analysis.
This person is not in any offices
Global Kinetics
lobal Kinetics Corporation (GKC) was established in 2007 to commercialise innovative technology developed by Professor Malcolm Horne, from the Florey Institute of Neuroscience & Mental Health (the largest Neuroscience research team in Australia and the Southern Hemisphere), and Dr Rob Griffiths, for the precise recording, quantification andreporting of movement symptoms of neurological disease.